物理性质
- 熔点170 °C (分解)(文献)
- 沸点56.5°C
- 密度1.86
- PH:3.6 (10g/l, H2O, 20°C)
- PSA:175.48
- LogP:-1.031 (est)
- 蒸汽压0.001Pa at 20°C
- 溶解性Water: Soluble(Lit.)
- 敏感性吸潮
- 外观形态白色晶体
- 储存条件-20°C
- 产品应用用作分析试剂,还原剂,影片,照相洗印药,也用于有机合成.
- 性质描述无色或白色结晶.熔点约170°C(分解),沸点56.5°C,密度1.204g/cm3.溶于冷水,乙醇和甲醇.极易吸湿.羟胺性质很不稳定,在常温下逐渐分解,在较高温度下会爆炸,故通常将其制成比较稳定的硫酸盐和盐酸盐.其中以硫酸羟胺为最常用.
欧盟法规
统一分类与标签REACH注册ECHA物质工作场所安全标识要求ECHA物质化妆品禁用物质清单C&L通报食品接触材料-禁用CMR物质REACH预注册废弃物危险特性清单专利信息
专利号:WO-2021014395-A1
优先权日:2019-07-24
标题:Process for the synthesis of deuterated capsaicin, capsaicinoids and synthetic capsaicin analogs
发明人:ORUGANTI SRINIVAS; AMRUTAPU SRAVANTH KUMAR; SAMPATH MAGESH; SEN SAIKAT
权利人:DR REDDY’S INST OF LIFE SCIENCES
摘要:The present application provides novel processes for the synthesis of deuterated intermediates of capsaicinoids, particularly II, III, IV and V of capsaicinoids, relating to pharmaceutical applications. The invention also provides novel intermediates of compounds of formula IX, XIV, XV, XVI, XVII, XVIII, XX and XXI utilized in the process of making deuterated capsaicin II, III, IV and V.
专利号:WO-2019202611-A1
优先权日:2018-04-21
标题:An improved process for the synthesis of ivabradine and its pharmaceutically acceptable salts
发明人:NANDEPU Venkateswara Rao; BOPPANA DURGA PRASAD
权利人:METROCHEM API PVT
摘要:: Disclosed herein is an improved process for the preparation of Ivabradine and pharmaceutically acceptable salts thereof. The invention more particularly disclosesthe synthesis of key intermediates viz.,(S)-N-[(4,5-dimethoxybenzocydobut-l-yl)-methyl]-N- (methyl)amine hydrochloride of Formula-II and 3-(3-Iodopropyl)-7,8-dimethoxy-1,3-dihydro-2H-3-benzapin-2-one of Formula-III, and its use in industrial synthesis of Ivabradine and pharmaceutically acceptable salts thereof.
专利号:WO-2022208508-A1
优先权日:2021-03-31
标 题:Scalable two step synthesis of molnupiravir
发明人:DATLA ANUPAMA; NAGRE PRASHANT; TAMORE JAGDISH; PRABHU MANOJKUMAR SADANAND; TRIVIKRAM SREENATH; KADAM SACHIN VASANT; DEGAONKAR GAJANAN SUBHASH; MURALIDHARAN KRISHNA; RUPRAJ NARAIN
权利人:FERMENTA BIOTECH LTD
摘要:The present invention provides a scalable two-step synthesis of molnupiravir. The reaction sequence involves the use of commercially easily available cytidine (1), and molnupiravir is formed through direct hydroxy amination of the cytidine followed by esterification of the primary alcohol without protecting dihydroxy groups (vicinal diols) i.e. without formation of acetonide.
专利号:US-2023002312-A1
优先权日:2019-11-20
标题:A continuous flow process for the synthesis of hydroxamic acid
发明人:PIMPALE MILIND JAGANNATH; KINI PRASHANT VASANT
权利人:UPL LTD
摘要:The present invention relates to a process for the synthesis of hydroxamic acids by continuous flow process wherein said process comprising reacting alkyl ester with hydroxyl amine salt in presence of base in a microreactor system and continuously producing hydroxamic acid.
专利号:WO-2022168106-A1
优先权日:2021-02-06
标题:Chemo-enzymatic process for synthesis of molnupiravir
发明人:DATLA ANUPAMA; NAGRE PRASHANT; TAMORE JAGDISH; PRABHU MANOJKUMAR SADANAND; TRIVIKRAM SREENATH
权利人:FERMENTA BIOTECH LTD
摘要:Disclosed herein is a process for synthesis of Molnupiravir from cytidine of using a lipase for esterification reaction. The process comprises of reacting compound of formula II with acetone in presence of sulphuric acid to obtain compound of formula III; enzymatically converting compound of Formula III to compound of Formula IV, and Hydroxyaminating Formula IV using Hydroxyl amine sulphate or hydrochloride followed by deprotection to obtain compound of formula I
专利号:US-2025101045-A1
优先权日:2022-01-18
标题:Synthesis of boron-containing amidoxime reagents and their application to synthesize functionalized oxadiazole and quinazolinone derivatives
发明人:DAS BHASKAR
权利人:LONG ISLAND UNIV
摘要:The present disclosure is concerned with borylated amidoximes useful in the synthesis of biologically relevant drug-like molecules, including functionalized oxadizole and quinazolinone derivatives. Also disclosed are methods of making borylated amidoximes, methods of making functionalized oxadiazole and quinazolinone compounds using the amidoximes, and functionalized oxadiazole and quinazolinone compounds prepared from borylated amidoximes. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.